Albinism

Revision as of 16:02, 21 August 2021 by Shadan Mehraban (talk | contribs)
Jump to navigation Jump to search

Albinism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Albinism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Albinism On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Albinism

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Albinism

CDC on Albinism

Albinism in the news

Blogs on Albinism

Directions to Hospitals Treating Albinism

Risk calculators and risk factors for Albinism

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Historical Perspective

Albinism was first discovered in 1908 by a British physician named Sir Archibald Edward Garrod. At first, it was believed that albinism is caused by a lack of melanocytes. In late 1950, it was proved that albinism is caused by tyrosine kinase inactivity.

Classification

Albinism is classified based on genetic mutation. The different types of albinism include: Oculocutaneous albinism(OCA), Hermansky-Pudlak syndrome (HPS),Chediak-Higashi syndrome (CHS),Ocular albinism (OA).

Pathophysiology

Melanocytes are derived from neural crest ectoderm and are found in hair follicles, skin, eyes, and inner ear. Melanocytes produce melanin which protects skin from ultraviolet. Tyrosinase converts tyrosine to DOPA, dopaquinone, and then melanin. Mutation in Tyrosinase enzyme is responsible for causing albinism. Additionally, melanin is responsible for development of the fovea, optic nerves, optic tracts, and visual cortex.Decussation of some optic nerve fibers at optic chiasm are essential for binocular vision. However, in albinism, most of nerve fibers decussate at optic chiasm and cause monocluar vision presented as strabismus. In ocular albinism, macular pigment is absent and fovea hypoplasia leads to decreased visual acuity.

Causes

Albinism is caused by genetic mutations that impair melanin synthesis. The number of melanocytes is preserved.

Differentiating Albinism from Other Diseases

Epidemiology and Demographics

The prevalence of albinism is estimated to be 1:17,000 to 1:20,000 in the general population.The Prevalence of different types of albinism varies and the most prevalent form is Oculocutaneous albinism 2 (OCA2).

Risk Factors

Albinism is inherited due to genetic mutations. Individuals with positive familial history are at risk of having albinism.

Screening

There is no screening test for albinism.Individuals with familial history of albinism can undergo genetic sequence analysis.

Natural History, Complications and Prognosis

The complications of albinism include skin cancer, sunburn, decreased visual acuity, poor self-image and self-isolation lead to depression. Patients with albinism has a normal life expectancy and do not have developmental delay or mental retardation.

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies |

See also

References

Template:WikiDoc Sources


Template:WS Template:WH